Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026
Quantum-Si Rg-A (NASDAQ Cons)
Závěr k 13.2.2026 Změna (%) Změna (USD) Objem obchodů (USD)
0,9906 1,59 0,02 2 820 354
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiQuantum-Si Inc
TickerQSI
Kmenové akcie:Ordinary Shares Class A
Kmenové akcie:Ordinary Shares Class B
RICQSI.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 143
Akcie v oběhu k 31.10.2025 215 489 665
MěnaUSD
Kontaktní informace
Ulice29 Business Park Drive
MěstoBRANFORD
PSČ06405
ZeměUnited States
Kontatní osobaJeffry Keyes
Funkce kontaktní osobyChief Financial Officer, Treasurer
Telefon12 034 587 100
Fax13026365454

Business Summary: Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Quantum-Si Inc revenues increased 6% to $2M. Net loss increased 23% to $83.7M. Revenues reflect Product increase of 5% to $1.9M, Service increase of 27% to $114K. Higher net loss reflects Molecule analysis segment loss increase of 22% to $95M. Basic Earnings per Share excluding Extraordinary Items increased from -$0.48 to -$0.43.
Odvětvová klasifikace
TRBC2012Biotechnology & Medical Research (NEC)
MGINDUSTRYSemiconductors
MGSECTORTechnology
NAICSSemiconductor and Related Device Manufacturing
NAICS2007Semiconductor & Related Device Mfg
NAICS1997Semiconductor and Related Device Manufacturing
SICSemiconductors/related Devices



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorJeffrey Hawkins4728.08.202310.10.2022
Chief Financial Officer, TreasurerJeffry Keyes5115.05.2023
General Counsel, Corporate SecretaryChristian LaPointe54
Chief Commercial OfficerTodd Bennett5517.09.202417.09.2024
Chief Product OfficerJohn Vieceli48